Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ESOMEPRAZOLE MAGNESIUM

ESOMEPRAZOLE MAGNESIUM

Standard Dose
EQ 20MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ESOMEPRAZOLE MAGNESIUM is listed in Drugs@FDA under application 214278 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ESOMEPRAZOLE MAGNESIUM Form and strength TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL - EQ 20MG BASE Sponsor DEXCEL Submission history Latest submission status date: 2022-05-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview ESOMEPRAZOLE MAGNESIUM is listed in Drugs@FDA under application 214278 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ESOMEPRAZOLE MAGNESIUM Form and strength TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL - EQ 20MG BASE Sponsor DEXCEL Submission history Latest submission status date: 2022-05-11 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.